Business news – Page 37
-
Business
US court overturns plant safety rule delay
Appeal finds Trump’s postponement of the 2017 Chemical Disaster Rule was unlawful
-
Opinion
Brute force and ignorance
It’s time for academia to get with the project plan and fail faster
-
News
Chemical reaction database in danger of closing down
Chemical Safety Library containing information on hazardous reactions is seeking a partner to help it stay afloat
-
Opinion
Feeding the confusion
When it comes to working out what foods do to our bodies, mostly we just don’t know
-
News
Accidents at cannabis cultivation facilities worry industry chemists
Incidents at marijuana growing facilities have caught the attention of the American Chemical Society, and its cannabis chemistry subdivision
-
Opinion
Behind enemy lines
When trade war breaks out, globalised industries ship out to dodge tariffs
-
Business
US approves first RNA interference drug
Alnylam’s Onpattro (patisiran) can treat a rare hereditary disease by silencing a specific gene
-
Business
Businesses use blockchain to take on trustlessness
Big companies are looking to blockchain technology to track transactions, finds Andy Extance, while upstarts exploit its cryptocurrency origins
-
Business
US government ordered to ban chlorpyrifos insecticide
Court gives EPA 60 days to finalise a ban, which was proposed under Obama but reversed by the Trump administration
-
News
EPA move could bring asbestos back in America
Health advocates fret at US environment agency’s proposal to make ‘new uses’ of asbestos-containing products legal, but EPA says not to worry
-
Business
Innovation in the open
Big companies are partnering with smaller ones – without trying to gobble up all their intellectual property, Anthony King finds
-
News
DuPont settles with US government over fatal chemical leak
Firm will pay $3.1 million to settle accident prevention violations linked to incident that killed four workers
-
Business
Vaccine scandal and heart drug recall show China’s pharma struggles
Fifteen arrests amid evidence of bribery related to vaccines, despite new standards and penalties for fraud
-
Business
Novartis exit from antibiotics a setback for race against resistance
Experts say business models must change to halt big pharma exodus
-
Business
Trump coaxes big promises from big pharma
Several drug industry giants are now pledging to freeze price increases in the US, but some suggest the movement is a publicity stunt or worse
-
Business
Drugmaker blocks Nevada execution
Alvogen obtains a restraining order to delay US prisoner’s execution, saying Nevada state obtained its sedative midazolam via ‘subterfuge’
-
Business
American chemical industry fights against US tariffs
The Trump administration has imposed an additional 10% tax on 6000 Chinese products, and more than 1500 are related to chemistry